Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Leuk Lymphoma. 2016 Aug 12;58(4):809–815. doi: 10.1080/10428194.2016.1213824

Table II.

Five-year survival for the whole cohort and propensity score-matched cohort.

Evaluable patients Propensity-score matched patients

Imaging response OS (%) PFS (%) OS (%) PFS (%)
PET-negative 88 65 88 65
PET-positive 78 51 77 53
CT-negative 87 64 87 65
CT-positive 78 54 77 57

CT, computed tomography; OS, overall survival; PET, positron emission tomography; PFS, progression-free survival.